TY - CHAP M1 - Book, Section TI - Sarcoidosis A1 - Marchell, Richard A2 - Kang, Sewon A2 - Amagai, Masayuki A2 - Bruckner, Anna L. A2 - Enk, Alexander H. A2 - Margolis, David J. A2 - McMichael, Amy J. A2 - Orringer, Jeffrey S. PY - 2019 T2 - Fitzpatrick's Dermatology, 9e AB - AT-A-GLANCESarcoidosis is a multisystem disease characterized by granulomatous inflammation of unknown etiology commonly occurring in the lung and the skin, but any organ system can be affected.The type of cutaneous lesion may suggest prognosis. Lupus pernio lesions are associated with chronic disease course and scarring. Erythema nodosum lesions portend an acute self-resolving course.Specific lesions of sarcoidosis have a varied clinical morphology, including macules, papules, plaques, nodules, and ulcerations.Topical, systemic, and intralesional corticosteroids are the mainstay of therapy.Patients initially diagnosed with cutaneous sarcoidosis should get baseline testing to look for deleterious systemic disease, including a physical examination; neurologic review of systems; a chest radiograph; an electrocardiogram; pulmonary function tests; urine analysis; complete blood count; comprehensive metabolic panel; serum calcium level; tuberculosis screening; and an ophthalmologic examination. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - dermatology.mhmedical.com/content.aspx?aid=1161328959 ER -